Previous Next

News Releases    Health & Medical

Translations: 


Health & Medical Results: 1951 item(s)
MUMBAI, India, 02 March 2021 /PRNewswire-AsiaNet/ -- Cipla Limited (BSE: 500087); (NSE: CIPLA EQ) (hereinafter referred to as "Cipla") today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Sumatriptan Nasal Spray, 20 mg from the United States Foo...
MUMBAI, India, March. 2, 2021/PRNewswire/ AsiaNet/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) referred to as "Cipla" today announced that its subsidiary, Cipla Gulf FZ LCC ("Cipla Gulf')is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines ...
PLYMOUTH MEETING, Pa., March 2, 2021 /PRNewswire-AsiaNet/ -- -- Trial achieved primary and secondary efficacy endpoints among all evaluable subjects in the Phase 3 multi-center, randomized, double-blind, placebo-controlled trial -- VGX-3100 is the first DNA medicine to achieve efficacy endpoints in a Pha...
MIAMI, March 1, 2021 /PRNewswire-AsiaNet/ -- Lennar Corporation (NYSE: LEN and LEN.B), the nation's leading homebuilder, today announced that it has been named #1 Most Admired Homebuilder on FORTUNE Magazine's 2021 List of World's Most Admired Companies ( https://c212.net/c/link/?t=0&l=en&o=...
SINGAPORE, March 1, 2021 /PRNewswire-AsiaNet/ -- TVM Capital Healthcare, a global specialist healthcare private equity firm operating in emerging markets, announces the successful sale of its portfolio company Cambridge Medical and Rehabilitation Center ("CMRC") to UAE-based publicly traded ...
LAUSANNE, Switzerland and SEONGNAM-SI GYEONGGI-DO, South Korea, Feb. 26, 2021 /PRNewswire/ - Korean and Swiss based companies leverage their oncology expertise to initiate a research collaboration to formulate novel antibody-drug conjugate (ADC) candidates Genome & Company (CEO: Jisoo Pae, Hansoo Park), a global leading immuno-oncolo...
DARMSTADT, Germany, Feb. 26, 2021 /PRNewswire-AsiaNet / -- MAGNIFY-MS retrospective analysis demonstrates patients develop protective antibody levels for at least six months following seasonal influenza and varicella zoster vaccines, irrespective of vaccine timing relative to MAVENCLAD dosing Initial f...
TOKYO, Feb. 25, 2021 /Kyodo JBN-AsiaNet/-- The Polyplastics Group is expanding its DURACON (R) polyoxymethylene (POM) PM series portfolio with the development of a new high-flow grade for drug contact and delivery applications for the medical and healthcare market. The new grade, DURACON P...
GENEVA, Feb. 24, 2021 /PRNewswire-AsiaNet/ -- -- Survey also shows that half of the responding countries have agreed to include dentists in their priority vaccination groups FDI World Dental Federation today [ http://www.fdiworlddental.org/vaccines ] called for more countries to enable...
SCHAFFHAUSEN, Switzerland, February 24, 2021, /PRNewswire-AsiaNet/-- Occlutech, a privately-held company, announced today the completion of patient enrolment in its pilot study to assess safety and efficacy of the novel Atrial Flow Regulator (AFR) in heart failure (HF) patients (PRELIEVE trial). PRELIEVE is a pr...

Previous Page Page 1 of 196 Next Page 1  2  3  4  5  6  7  8  9  10  ... Go to page Go